To identify tumor-related immune cells and whether specific immune cell types were differentially enriched in either ERG + or ERG− samples, we analyzed the T-cell population and identified CD4 and CD8 T-cells, regulatory T-cells (Treg), and NK cells based on differentially expressed genes (Fig. 7a). This evidence concerns the gene CD8A and neoplasm.